What is estradiol in men — and when does it become a problem on TRT?

Men naturally produce estradiol (E2) via aromatization of testosterone, a small but physiologically essential amount supporting bone density, libido, cognitive function, and cardiovascular health, but excess estradiol from supraphysiological testosterone conversion (as can occur with TRT, particularly in men with excess visceral fat and high aromatase activity) produces symptoms including gynecomastia, water retention, irritability, reduced libido, and disrupted sleep (Jankowska et al., Eur J Heart Fail, 2009).

The estradiol management error in TRT is frequently excessive AI (aromatase inhibitor) use, anastrozole prescribed aggressively to suppress all estradiol conversion, driving E2 to very low levels and causing joint pain, fatigue, cognitive difficulty, and loss of libido that men then attribute to their underlying testosterone problem. The correct clinical target for men on TRT is an estradiol of 20–40 pg/mL, within the physiological male range, not suppressed to post-menopausal levels.

Honesty Scale: Solid (1) for the physiological role of estradiol in men. Solid (1) for the over-suppression risk with excessive AI use.

What to do: If you are on TRT and being prescribed anastrozole, ensure your estradiol is being tested with the sensitive estradiol assay (LC-MS/MS method, not the standard immunoassay which overestimates in men) before each dosing decision. Target 20–40 pg/mL, not minimum possible.

For the full picture, read The Testosterone/TRT Deep Dive